Anti-obesity drugs are pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories. The main treatment modalities for overweight and obese individuals remain dieting and physical exercise.
This report contains market size and forecasts of Anti-obesity Drugs in global, including the following market information:
- Global Anti-obesity Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Anti-obesity Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Anti-obesity Drugs companies in 2021 (%)
The global Anti-obesity Drugs market was valued at 1876.9 million in 2021 and is projected to reach US$ 5385.2 million by 2028, at a CAGR of 16.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Peripherally Acting Anti-obesity Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-obesity Drugs include Merck, Novo Nordisk, Pfizer, Arena Pharmaceuticals, Roche, GlaxoSmithKline, Orexigen Therapeutics, Vivus and Amylin, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-obesity Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-obesity Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-obesity Drugs Market Segment Percentages, by Type, 2021 (%)
- Peripherally Acting Anti-obesity Drugs
- Centrally Acting Anti-obesity Drugs
Global Anti-obesity Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-obesity Drugs Market Segment Percentages, by Application, 2021 (%)
Global Anti-obesity Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Anti-obesity Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-obesity Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Anti-obesity Drugs revenues share in global market, 2021 (%)
- Key companies Anti-obesity Drugs sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Anti-obesity Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Novo Nordisk
- Pfizer
- Arena Pharmaceuticals
- Roche
- GlaxoSmithKline
- Orexigen Therapeutics
- Vivus
- Amylin
- Alizyme
- Boehringer Ingelheim
- Eisai
